17 - 20 Jun 2024 | Amsterdam

Thrills, pills, & VC bills: What will it take to unleash innovation in the world of drug development?

Speakers:

Edward Kliphuis

PartnerSofinnova Partners

Michael Chen

Co-Founder & CEONuclera

Ignacio H. Medrano

Neurologist, Founder & Chief Medical OfficerSAVANA

Geraldine O'Keeffe

PartnerEQT Partners

Karen Madden

Chief Technology OfficerThe Life Science Business of Merck

About this Session:

Drug development and rapid innovation are unlikely bedfellows. Drug development is, by its very nature, a long-winded, wieldy, hyper-expensive process. However, the integration of artificial intelligence, high-throughput screening techniques, and advanced computational modelling has catalysed the identification of potential drug candidates and expedited the prediction of their efficacy and safety profiles. Are we finally entering an era where the once-distant notions of drug development and rapid innovation are becoming increasingly intertwined? And what will it take for the industry to fully harness the potential of novel tools and strategies to address unmet medical needs in a more efficient and agile manner?

HLTH Europe 2024